Tianeptine sodium constitutes novel antidepressant drug primarily indicated for the alleviation of significant depression and, in some countries, may be non-approved employed for irritable bowel syndrome . Its mechanism involves a unusual therapeutic approach compared to common selective serotonin reuptake inhibitors ( selective serotonin inhibitor